Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Peer

Showing results (11-20 of 181) with videos related to

Pageof 19
Sort By:
Chemical Society Reviews|November 17, 2011
Polysaccharides as building blocks for nanotherapeuticsShoshy Mizrahy, Dan Peer
Neoplasia (New York, N.Y.)|July 17, 2004
Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal Doxorubicin in syngeneic and human xenograft mouse tumor modelsDan Peer, Rimona Margalit
Idrugs : the Investigational Drugs Journal|August 28, 2010
Overcoming RNAi transduction in leukocytes using targeted and stabilized nanoparticlesRofa Elfakess, Dan Peer
Cancer Letters|August 15, 2013
Omics-based nanomedicine: the future of personalized oncologyDaniel Rosenblum, Dan Peer
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 21, 2018
Gene Silencing in the Right Place at the Right TimeAnna Gutkin, Dan Peer
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 10, 2023
Design of experiments in the optimization of nanoparticle-based drug delivery systemsRiccardo Rampado, Dan Peer
Molecular Therapy. Nucleic Acids|January 26, 2026
A symphony of immunity: How HPV mRNA-LNP vaccination orchestrates systemic anti-tumor responsesUri Elia, Dan Peer
Nanotechnology|May 14, 2010
RNAi nanomedicines: challenges and opportunities within the immune systemShiri Weinstein, Dan Peer
Seminars in Immunology|September 12, 2017
Delivering the right message: Challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics-An innate immune system standpointYasmin Granot, Dan Peer
Advanced Drug Delivery Reviews|December 12, 2018
Engineering lymphocytes with RNAiSrinivas Ramishetti, Dan Peer
Pageof 19

Showing results (11-20 of 181) with videos related to

Sort By:
Pageof 19
Chemical Society Reviews|November 17, 2011
Polysaccharides as building blocks for nanotherapeuticsShoshy Mizrahy, Dan Peer
Neoplasia (New York, N.Y.)|July 17, 2004
Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal Doxorubicin in syngeneic and human xenograft mouse tumor modelsDan Peer, Rimona Margalit
Idrugs : the Investigational Drugs Journal|August 28, 2010
Overcoming RNAi transduction in leukocytes using targeted and stabilized nanoparticlesRofa Elfakess, Dan Peer
Cancer Letters|August 15, 2013
Omics-based nanomedicine: the future of personalized oncologyDaniel Rosenblum, Dan Peer
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 21, 2018
Gene Silencing in the Right Place at the Right TimeAnna Gutkin, Dan Peer
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 10, 2023
Design of experiments in the optimization of nanoparticle-based drug delivery systemsRiccardo Rampado, Dan Peer
Molecular Therapy. Nucleic Acids|January 26, 2026
A symphony of immunity: How HPV mRNA-LNP vaccination orchestrates systemic anti-tumor responsesUri Elia, Dan Peer
Nanotechnology|May 14, 2010
RNAi nanomedicines: challenges and opportunities within the immune systemShiri Weinstein, Dan Peer
Seminars in Immunology|September 12, 2017
Delivering the right message: Challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics-An innate immune system standpointYasmin Granot, Dan Peer
Advanced Drug Delivery Reviews|December 12, 2018
Engineering lymphocytes with RNAiSrinivas Ramishetti, Dan Peer
Pageof 19